Show
Sort by
-
- Journal Article
- A1
- open access
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
-
- Journal Article
- A1
- open access
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
-
- Journal Article
- A2
- open access
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
-
- Journal Article
- A1
- open access
Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort
-
- Journal Article
- A1
- open access
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
-
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study
-
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
-
- Journal Article
- A1
- open access
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
-
- Journal Article
- A1
- open access
External validation of a predictive model for acute skin radiation toxicity in the REQUITE Breast Cohort